|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| Dockets Entered
On April 14, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function
Claim Notification Letters Dietary
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using
Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids
in Nutrition Labeling; Consumer research to consider possible footnote
statements
|
|
|
| 2003P-0126
|
| Refrain from approving
(ANDA)for Levothyroxine Sodium Tablet
|
|
|
|
|
| 2003P-0387
|
| Request that the Commissioner
of Food and Drug take action described methodology for oral levothyroxine
sodium drug products
|
|
|
|
|
| 2004D-0002
|
| Guidance for Industry
and FDA Staff; Saline, Silicone Gel, and Alternative Breast Implants
|
|
|
|
|
| 2004P-0175
|
| ANADA for ageneric
intravaginal progesterone insert for cattle that differs from the
pioneer product (EAZI-BREED TM CIDR
|
|
|
|
|
| 2004P-0177
|
| Provide
Certification to Congress Under Section 804(l) of Chapter VII of the
Federal Food, Drug, and Cosmetics Act, and to Authorize a Pilot Program
for Imporatation of Prescription Drugs in Illinois
|
|
|
|
|
|
|
|
|
|
|
| 1993D-0398
|
| Microbiological
Testing Antimicrobial Drug Residues in Foods
|
|
|
|
|
| EC 6
|
| mother of 3
|
| Vol #:
|
| 1
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure
Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
13586
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13587
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13588
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13589
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13590
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13591
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13592
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13593
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13594
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13595
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13596
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13597
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| LET
13598
|
| General Vitamin Corporation
|
| Vol #:
|
| 113
|
|
|
|
|
| 2001P-0075
|
| Switch Status of
Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| EC 713
|
| Miss. Orit Zeevi
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 714
|
| Dr. Charles Brady
|
| Vol #:
|
| 163
|
|
|
|
|
| EC 715
|
| Mr. David Anderson
|
| Vol #:
|
| 163
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride
using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| EMC 158
|
| Robyn Hunter
|
| Vol #:
|
| 3
|
|
|
|
|
| EMC 159
|
| Maria Stahl
|
| Vol #:
|
| 3
|
|
|
|
|
| EMC 160
|
| Alan Masliuk
|
| Vol #:
|
| 3
|
|
|
|
|
| 2002D-0369
|
| Developmental Toxicity
Testing
|
|
| | | | | | | | |
|
|
|
|
| EC 1
|
| mother of 3
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003D-0498
|
| Compliance Program Guidance Manual 7371.009; BSE/Ruminant Feed Ban Inspections; Availability
|
|
|
|
|
| EC 11
|
| mother of 3
|
| Vol #:
|
| 1
|
|
| |
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EC
15
Attachment
|
| American Bakers Association
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003N-0312
|
| Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
|
|
|
|
|
| EC 2
|
| mother of 3
|
| Vol #:
|
| 4
|
|
|
|
|
| 2003P-0126
|
| Refrain from approving (ANDA)for Levothyroxine Sodium Tablet
|
|
|
|
|
| C 3
|
| Fredric J. Cohen, M.D.
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003P-0387
|
| Request that the Commissioner of Food and Drug take action described methodology for oral levothyroxine sodium drug products
|
|
|
|
|
| C 3
|
| Fredric J. Cohen, M.D.
|
| Vol #:
|
| 3
|
|
|
|
|
| 2004D-0002
|
| Guidance for Industry and FDA Staff; Saline, Silicone Gel, and Alternative Breast Implants
|
|
|
|
|
| C 11
|
| R.M. Rahn
|
| Vol #:
|
| 1
|
|
|
|
|
| C
12
|
| Breast Cancer Action
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
8
|
| National Women's Health Network
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
9
|
| National Center for Policy Research for Women & Families
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
10
|
| University of Utah SOM
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 11
|
| Neal R. Reisman, M.D., J.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 12
|
| Paul R. Weiss, M.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 13
|
| Bruce Cunningham
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 14
|
| James H. Wells, M.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 15
|
| Marlene Keeling
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 16
|
| Scott L. Spear, M.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 17
|
| Karol A. Gutowski, M.D. FACS
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 18
|
| Karen M. Backer, Ph.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 19
|
| Anne Taylor, M.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0175
|
| ANADA for ageneric intravaginal progesterone insert for cattle that differs from the pioneer product (EAZI-BREED TM CIDR
|
|
|
|
|
| ACK
1
|
| Intervet Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
|
| Intervet Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0177
|
| Provide Certification to Congress Under Section 804(l) of Chapter VII of the Federal Food, Drug, and Cosmetics Act, and to Authorize a Pilot Program for Imporatation of Prescription Drugs in Illinois
|
|
|
|
|
|
|
|
|
| ACK
1
|
| HFA-305 to Illinois Attorney Generals Office
|
| Vol #:
|
| 1
|
|
